Pro Medicus Limited (ASX:PME)
Australia flag Australia · Delayed Price · Currency is AUD
182.33
+5.72 (3.24%)
Aug 11, 2026, 4:11 PM AEST

Pro Medicus Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Revenue
240.57212.98161.5124.993.4667.88
Other Revenue
-----0.18
240.57212.98161.5124.993.4668.06
Revenue Growth
12.95%31.87%29.30%33.64%37.31%19.79%
Cost of Revenue
0.320.310.30.540.470.49
Gross Profit
240.25212.67161.2124.369367.57
Selling, General & Admin
55.4747.0438.731.0721.5616.76
Other Operating Expenses
-1.480.611.211.292.80.99
Operating Expenses
61.7254.8848.4140.2831.6824.94
Operating Income
178.53157.79112.7984.0861.3142.63
Interest & Investment Income
8.127.564.832.430.65-
Currency Exchange Gain (Loss)
-2.18-2.03-1.12-0.391.120.24
Other Non Operating Income (Expenses)
---0--
Pretax Income
333.34163.31116.586.1363.0842.87
Income Tax Expense
98.6548.133.725.4818.6412.02
Net Income
234.7115.2282.7960.6544.4430.85
Net Income to Common
234.7115.2282.7960.6544.4430.85
Net Income Growth
103.70%39.16%36.52%36.47%44.06%33.69%
Shares Outstanding (Basic)
104104104104104104
Shares Outstanding (Diluted)
105105105105105105
Shares Change
-0.00%0.01%0.06%0.01%-0.01%0.13%
EPS (Basic)
2.251.100.790.580.430.30
EPS (Diluted)
2.241.100.790.580.420.29
EPS Growth
103.69%39.19%36.38%36.47%44.07%33.48%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Free Cash Flow
127.37110.8981.6762.2461.3438.71
Free Cash Flow Per Share
1.221.060.780.590.590.37
Dividend Per Share
0.6200.5500.4000.3000.2200.150
Dividend Growth
12.73%37.50%33.33%36.36%46.67%25.00%
Gross Margin
99.87%99.86%99.81%99.56%99.50%99.28%
Operating Margin
74.21%74.09%69.84%67.32%65.60%62.63%
Profit Margin
97.56%54.10%51.27%48.56%47.55%45.32%
Free Cash Flow Margin
52.95%52.07%50.57%49.83%65.63%56.88%
EBITDA
178.91158.12113.0684.3761.5942.89
EBITDA Margin
74.37%74.24%70.00%67.55%65.89%63.02%
D&A For EBITDA
0.380.330.270.290.270.26
EBIT
178.53157.79112.7984.0861.3142.63
EBIT Margin
74.21%74.09%69.84%67.32%65.60%62.63%
Effective Tax Rate
29.59%29.45%28.93%29.58%29.54%28.04%
Revenue as Reported
248.69220.54166.33127.3394.1168.06
Advertising Expenses
-3.742.892.521.950.32